ClinicalTrials.Veeva

Menu

Sensitivity and Specificity of Leucocytes Subpopulation Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial

M

Minia University

Status

Not yet enrolling

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT06612307
Anet 19-2

Details and patient eligibility

About

Leucocyte subpopulation and platelet indices analysis can predict clinical outcome

Enrollment

161 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult population of both sex, aged 20 or older admitted to the ICU with a diagnosis of sepsis were screened for inclusion within 48 h of presentation to the hospital. Sepsis was defined as per the Sepsis-3 definition, 6 ie, the presence of suspected or documented infection with organ dysfunction determined by an acute increase of sequential organ failure assessment (SOFA) score by 2 or more points

Exclusion criteria

  • Patient refusal.
  • History of surgery in the last 7 days from admission.
  • Immunocompromised population ( post-transplantation, steroid use > 5 mg per day, malignancy, HIV, on chemotherapy).
  • Population with history of thrombocytopenia ( ITP, aplastic anemia, drug induced)
  • History of thrombocytosis ( idiopathic thrombocytosis, post-splenectomy)
  • History of platelet transfusion one week before admission.
  • Bone marrow transplanted population .
  • Chronic liver and kidney disease.
  • Von-Willebrand disease.
  • Patients on antiplatelet therapy ( Aspirin, clopidogrel).
  • Thrombocytopenic population ( ITP, TTP,HELLP) .
  • Myelodysplastic or proliferative patients.
  • Blood dyscarsiasis
  • Obestetric parturients.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems